PHOTO
Abu Dhabi: Tawam Hospital, part of Abu Dhabi Health Services Company, (SEHA), the UAE’s largest healthcare network, is the first center in the country to become recertified with the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) for 6 Oncology Programs, following its initial certification in 2017. The CCPC recognition is rewarded to facilities that are already JCI-approved and that provide general medical care and excel at a defined care service.
Renowned for its comprehensive cancer care, Tawam Hospital received the CCPC endorsement in 2017 and recertification in 2021 for six cancer programs, namely Breast, Cervix, Colon, Lung, Prostate and Rectum.
During the evaluation, surveyors explore the facility’s international patient safety goals, program leadership and management, delivery of clinical care, support of self-management for patients and caregivers, clinical information management, and performance, measurement, and improvement, with a total of 46 standards and 184 measurable elements against each cancer program. Out of the total 184 measurable elements for each program, Tawam Hospital successfully met 183 with the remaining 1 partially met, resulting in a compliance score of 99.5 per cent.
Saeed Jaber Al Kuwait, Chief Executive Officer, Tawam Hospital, said: “We are very proud to maintain our leading position in the UAE’s healthcare landscape as the first facility to firstly receive the Golden Seal of Approval certification in 2017 for oncology services and then be recognized again this year. Such acknowledgements reassure us that we are moving in the right direction, ensuring excellence in care is delivered to everyone who walks through our doors, irrespective of whether their medical need is general or specialized. Being able to respond to the demands of a more defined patient population demonstrates our ability to remain agile and customize our approach, within a clearly defined set of compliance and safety standards.”
Tawam Hospital received its initial Joint Commission International (JCI) accreditation in 2006, and since then continues to meet the JCI’s symbol of quality that reflects the facility’s commitment to providing safe and effective patient care. JCI’s hospital standards are developed in consultation with worldwide healthcare experts and providers, measurement experts, and patients. The standards are informed by scientific literature and expert consensus to help organizations measure, assess, and improve performance.
-Ends-
About SEHA:
The Abu Dhabi Health Services Company PJSC–SEHA – is an independent, public joint stock company created to develop the curative activities of the public healthcare system in Abu Dhabi. The company owns and operates all the public hospitals and clinics of the Emirate of Abu Dhabi.
SEHA is part of ADQ, one of the region’s largest holding companies with a broad portfolio of major enterprises spanning key sectors of Abu Dhabi’s diversified economy.
SEHA is committed to continuous improvement of customer care to recognized international standards and providing the community with world-class healthcare. SEHA operates 13 hospitals with 3,385 beds, 70 ambulatory care, family care and urgent care centers and 2 blood banks. Its facilities accommodate 117,162 inpatients annually and conduct 43,262 surgeries, as well as treating more than five million outpatients. SEHA is one of the largest integrated healthcare providers in the Middle East with more than 18,000 doctors, nurses, ancillary care, and administrative personnel. Learn more at www.seha.ae
About Joint Commission International Accreditation (JCIA)
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
